http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2119668-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da3029f345be698b0350820bc95cb21a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c7e13fa20a22154b9c8a0ae2220e18f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-312
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
filingDate 1994-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67f6556cf2c4ec0d7a00ea3c027f0726
publicationDate 1998-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2119668-C1
titleOfInvention Method of differential diagnosis of fibroadenoma and breast cancer in histological slices
abstract FIELD: medicine, pathological anatomy. SUBSTANCE: method involves rehydration of histological slices in samples taken off at surgery operation followed by removing paraffin residues. Activity of endogeneous peroxidase and nonspecific sorption of immunoglobulins are inhibited and histological slices are treated with the primary antibodies raised to alpha-2-macroglobulin and alpha-2-glycoprotein. Histological slices are incubated with the secondary antibodies and selective staining of alpha-2-macroglobulin or alpha-2-glycoprotein (yellow-brown colors) are obtained. Detection degree is determined on the basis of staining intensity. Tumor is diagnosed as fibroadenoma at high degree of detection of alpha-2-macroglobulin (brown color) and at low degree of detection of alpha-2-glycoprotein (pale-yellow color). Breast cancer is diagnosed at low degree of detection of alpha-2-macroglobulin (pale-yellow color) and at high degree of detection of alpha-2-glycoprotein (brown color). EFFECT: improved precision of diagnosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2730993-C2
priorityDate 1994-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161604827
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJC5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11287
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3T478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100173946
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJD2
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24153
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID513856
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100006947
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453766669
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID232345

Total number of triples: 30.